biotech
biotech Articles
Ardelyx shares jumped on Tuesday after the firm announced positive results from its late-stage study in dialysis patients who have uncontrolled hyperphosphatemia.
Published:
Last Updated:
Cidara Therapeutics shares saw a massive gain on Tuesday after the firm announced that it has entered into a strategic partnership with Mundipharma to develop and commercialize Cidara’s treatment...
Published:
Last Updated:
On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.
Published:
Last Updated:
Medicines Co. shares made a handy gain on Tuesday after the firm announced results from its late-stage trial in the treatment of low-density lipoprotein cholesterol.
Published:
Last Updated:
Sometimes too much good news can inflate a company's shares beyond what the market can easily justify. That appears to be the case for Veeva Systems, given the post-earnings reaction.
Published:
Last Updated:
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
Published:
Last Updated:
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
Published:
Last Updated:
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
Published:
Last Updated:
Medicines Company shares jumped early on Monday after the firm announced results from its late-stage cholesterol study of inclisiran.
Published:
Last Updated:
Retrophin shares hit a multiyear low after the firm announced late-stage results from its study in patients with pantothenate kinase-associated neurodegeneration.
Published:
Last Updated:
Altimmune shares jumped on Wednesday after the company announced that the Biomedical Advanced Research and Development Authority is modifying its existing anthrax vaccine development contract with...
Published:
Last Updated:
Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. 24/7 Wall St. has picked a few of those standouts to highlight.
Published:
Last Updated:
Endo International announced on Tuesday that its Endo and Par Pharma subsidiaries have reached a settlement in principle with the Cuyahoga and Summit counties in Ohio.
Published:
Last Updated:
Moderna shares jumped late on Monday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its investigational Zika vaccine (mRNA-1893)...
Published:
Last Updated: